Kiefer JA - Search Results

1

Osteoprotegerin in prostate cancer bone metastasis.

Corey E, Brown LG, Kiefer JA, Quinn JE, Pitts TE, Blair JM, Vessella RL. Corey E, et al. Among authors: kiefer ja. Cancer Res. 2005 Mar 1;65(5):1710-8. doi: 10.1158/0008-5472.CAN-04-2033. Cancer Res. 2005. PMID: 15753366

2

The effect of osteoprotegerin administration on the intra-tibial growth of the osteoblastic LuCaP 23.1 prostate cancer xenograft.

Kiefer JA, Vessella RL, Quinn JE, Odman AM, Zhang J, Keller ET, Kostenuik PJ, Dunstan CR, Corey E. Kiefer JA, et al. Clin Exp Metastasis. 2004;21(5):381-7. doi: 10.1007/s10585-004-2869-0. Clin Exp Metastasis. 2004. PMID: 15672862 Free article.

3

Inhibition of androgen-independent prostate cancer by estrogenic compounds is associated with increased expression of immune-related genes.

Coleman IM, Kiefer JA, Brown LG, Pitts TE, Nelson PS, Brubaker KD, Vessella RL, Corey E. Coleman IM, et al. Among authors: kiefer ja. Neoplasia. 2006 Oct;8(10):862-78. doi: 10.1593/neo.06328. Neoplasia. 2006. PMID: 17032503 Free PMC article.

4

Osteopontin: possible role in prostate cancer progression.

Thalmann GN, Sikes RA, Devoll RE, Kiefer JA, Markwalder R, Klima I, Farach-Carson CM, Studer UE, Chung LW. Thalmann GN, et al. Among authors: kiefer ja. Clin Cancer Res. 1999 Aug;5(8):2271-7. Clin Cancer Res. 1999. PMID: 10473115

5

Type I collagen-mediated changes in gene expression and function of prostate cancer cells.

Kiefer J, Alexander A, Farach-Carson MC. Kiefer J, et al. Cancer Treat Res. 2004;118:101-24. doi: 10.1007/978-1-4419-9129-4_5. Cancer Treat Res. 2004. PMID: 15043190 Review.

6

Functional evidence implicating S100P in prostate cancer progression.

Basu GD, Azorsa DO, Kiefer JA, Rojas AM, Tuzmen S, Barrett MT, Trent JM, Kallioniemi O, Mousses S. Basu GD, et al. Among authors: kiefer ja. Int J Cancer. 2008 Jul 15;123(2):330-339. doi: 10.1002/ijc.23447. Int J Cancer. 2008. PMID: 18452169 Free article.

7

Type I collagen-mediated proliferation of PC3 prostate carcinoma cell line: implications for enhanced growth in the bone microenvironment.

Kiefer JA, Farach-Carson MC. Kiefer JA, et al. Matrix Biol. 2001 Nov;20(7):429-37. doi: 10.1016/s0945-053x(01)00159-7. Matrix Biol. 2001. PMID: 11691583

8

EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers.

Lugli A, Spichtin H, Maurer R, Mirlacher M, Kiefer J, Huusko P, Azorsa D, Terracciano L, Sauter G, Kallioniemi OP, Mousses S, Tornillo L. Lugli A, et al. Clin Cancer Res. 2005 Sep 15;11(18):6450-8. doi: 10.1158/1078-0432.CCR-04-2458. Clin Cancer Res. 2005. PMID: 16166419

9

Advancing a clinically relevant perspective of the clonal nature of cancer.

Ruiz C, Lenkiewicz E, Evers L, Holley T, Robeson A, Kiefer J, Demeure MJ, Hollingsworth MA, Shen M, Prunkard D, Rabinovitch PS, Zellweger T, Mousses S, Trent JM, Carpten JD, Bubendorf L, Von Hoff D, Barrett MT. Ruiz C, et al. Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):12054-9. doi: 10.1073/pnas.1104009108. Epub 2011 Jul 5. Proc Natl Acad Sci U S A. 2011. PMID: 21730190 Free PMC article.

10

Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer.

Azorsa DO, Gonzales IM, Basu GD, Choudhary A, Arora S, Bisanz KM, Kiefer JA, Henderson MC, Trent JM, Von Hoff DD, Mousses S. Azorsa DO, et al. Among authors: kiefer ja. J Transl Med. 2009 Jun 11;7:43. doi: 10.1186/1479-5876-7-43. J Transl Med. 2009. PMID: 19519883 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page